ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2015, Vol. 24 ›› Issue (3): 218-224.

• 论文 • 上一篇    下一篇

糖尿病肾病患者心血管钙化的发生率及特点

  

  • 出版日期:2015-06-28 发布日期:2015-07-01

The incidence and characteristics of cardiovascular calcification in patient with diabetic nephropathy

  • Online:2015-06-28 Published:2015-07-01

摘要:

摘要:观察糖尿病肾病CKD患者心血管钙化的发生情况,并分析其影响因素。
方法:选取CKD 2-5期非透析糖尿病肾病患者270例(CKD2期40例,CKD3期121例,CKD4期63例,CKD5期46例),完善心血管钙化的相关实验室检查,选用螺旋CT检测冠状动脉钙化评分,腹部侧位平片检测腹主动脉钙化评分,心脏彩超检测心脏瓣膜钙化情况,并采用Logistic回归分析心血管钙化的相关危险因素。
结果:自CKD2期至5期,患者血磷逐渐升高,血钙逐渐降低,全段甲状旁腺激素逐渐升高,25羟维生素D逐渐下降(P<0.01)。所有患者心血管钙化发生率为70.3%,其中冠状动脉钙化、腹主动脉钙化和瓣膜钙化发生率分别为55.1%、43.4%和23.9%。CKD2-5期心血管钙化的总发生率分别为72.5%,73.6%,66.7%和63.0%。心血管钙化与年龄、糖尿病病程、高血压病程、心血管疾病史、颈部血管粥样斑块等相关,而与性别、血脂异常、血钙、血磷、全段甲状旁腺激素及CKD分期无关。其中年龄、心血管疾病史和颈部血管粥样斑块是冠状动脉和腹主动脉钙化的独立危险因素,年龄是心脏瓣膜钙化的独立危险因素。
结论:糖尿病肾病CKD患者心血管钙化发生率高,在CKD2期钙磷代谢紊乱不明显时即已出现明显钙化。心血管钙化发生率与传统心血管疾病危险因素相关,而与钙磷代谢指标及CKD分期无显著相关。 

关键词: 糖尿病肾病, 慢性肾脏病-矿物质和骨异常, 心血管钙化

Abstract:

ABSTRACT
Objective: To evaluate the distribution of cardiovascular calcification and its risk factors in diabetic nephropathy patients with renal dysfunction. Methodology: Two hundred seventy diabetic nephropathy patients with renal dysfunction {chronic kidney disease (CKD) stages 2-5 and non-dialysis} were enrolled into this cross-sectional study. Coronary calcification score was detected by spiral computed tomography, abdominal aortic calcification score was detected by abdominal lateral radiographs, and the valve calcification was examined by cardiac ultrasound. Information about mineral disorder was collected. The related risk factors for cardiovascular calcification were evaluated by Logistic regression. Results: There were 40 patients in CKD stage 2, 121 in stage 3 , 63 in stage 4 and 46 in stage 5 . With the progression of CKD stages, the level of serum phosphorus was increased and serum calcium was decreased gradually, while the level of intact parathyroid hormone was increased and 25-Hydroxyvitamin D was decreased (P<0.01). The total calcification prevalence was 70.3% in these patients, and the prevalence of coronary calcification, abdominal aortic calcification and valve calcification was 55.1%, 43.4% and 23.9%, respectively. The total calcification prevalence in CKD stages 2-5 was 72.5%, 73.6%, 66.7% and 63.0%, respectively. The incidence of cardiovascular calcification was associated with the age, duration of diabetes, duration of hypertension, history of cardiovascular diseases and the present of carotid artery plaque. No significant correlations were observed between calcification and sex, dyslipidemia, serum phosphorus and calcium, intact parathyroid hormone or stages of CKD. Among those, age, history of cardiovascular diseases and the present of carotid artery plaque were independent risk factors for coronary and abdominal aortic calcification, while the age was the only independent risk factor for the valve calcification. Conclusion: The prevalence of cardiovascular calcification was high in diabetic nephropathy patients with renal dysfunction, even in early stage of CKD (stage 2) when mineral disorder was not obvious. The incidence of cardiovascular calcification was associated with traditional cardiovascular risk factors but not mineral disorder or stages of CKD.

Key words: diabetic nephropathy, chronic kidney disease-mineral and bone disorder,, cardiovascular calcification